BIT
ARIA

BlackRock Institutional Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Institutional Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$60.5M Buy
4,862,195
+106,375
+2% +$1.28M 0.01% 1220
2016
Q3 		$65.1M Buy
4,755,820
+209,319
+5% +$2.1M 0.01% 1117
2016
Q2 		$33.6M Buy
4,546,501
+41,983
+0.9% +$315K 0.01% 1491
2016
Q1 		$28.8M Sell
4,504,518
-16,918
-0.4% -$94.8K ﹤0.01% 1570
2015
Q4 		$28.3M Buy
4,521,436
+197,765
+5% +$1.3M ﹤0.01% 1614
2015
Q3 		$25.3M Sell
4,323,671
-340,897
-7% -$2.63M ﹤0.01% 1668
2015
Q2 		$38.6M Sell
4,664,568
-234,996
-5% -$2.08M 0.01% 1454
2015
Q1 		$40.4M Sell
4,899,564
-3,714
-0.1% -$27.5K 0.01% 1456
2014
Q4 		$33.7M Buy
4,903,278
+88,609
+2% +$554K 0.01% 1559
2014
Q3 		$26M Sell
4,814,669
-13,725
-0.3% -$80.2K ﹤0.01% 1719
2014
Q2 		$30.8M Buy
4,828,394
+248,617
+5% +$1.71M 0.01% 1660
2014
Q1 		$36.9M Sell
4,579,777
-231,881
-5% -$1.81M 0.01% 1528
2013
Q4 		$32.8M Buy
4,811,658
+356,687
+8% +$1.93M 0.01% 1569
2013
Q3 		$82M Sell
4,454,971
-55,984
-1% -$1.09M 0.02% 901
2013
Q2 		$78.9M Buy
+4,510,955
New +$80M 0.02% 869

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

BlackRock Institutional Trust's ARIA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Ariad Pharmaceuticals Inc (ARIA) stake by 2.2% in Q4 2016, buying an estimated $1.28M and bringing the position to 4,862,195 shares worth $60.5M. The position accounts for 0.01% of the portfolio, ranked #1220.

BlackRock Institutional Trust first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. The position peaked at $82M in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • BlackRock Institutional Trust held 4,862,195 shares of Ariad Pharmaceuticals Inc worth $60.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 106,375 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $1.28M.
  • Ariad Pharmaceuticals Inc made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1220 holding.
  • BlackRock Institutional Trust first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Ariad Pharmaceuticals Inc position peaked at $82M in Q3 2013.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.